APA (7th ed.) Citation

Hui, R., Liu, X., Fan, Z., Ji, H., Wei, D., & Ren, G. (2024). The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma. Journal of Cancer, 15(6), 1668. https://doi.org/10.7150/jca.92689

Chicago Style (17th ed.) Citation

Hui, Rongrong, Xiulan Liu, Zongyu Fan, Honghai Ji, Dongliang Wei, and Guoxin Ren. "The Efficacy of Cetuximab Plus PD-1 Inhibitors as Salvage Therapy in PD-1 Refractory Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma." Journal of Cancer 15, no. 6 (2024): 1668. https://doi.org/10.7150/jca.92689.

MLA (9th ed.) Citation

Hui, Rongrong, et al. "The Efficacy of Cetuximab Plus PD-1 Inhibitors as Salvage Therapy in PD-1 Refractory Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma." Journal of Cancer, vol. 15, no. 6, 2024, p. 1668, https://doi.org/10.7150/jca.92689.